Technology

Building the Future of E. coli Biomanufacturing with Protein Secretion

Trond Erik Vee Aune, Ph.D.; Jostein Malmo, Ph.D.; Dominik Bahiense de Mello

Vectron Biosolutions

Real-World Data

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Pharma's Almanac

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

Pharma's Almanac

Biomanufacturing

On the Journey to a New Industry Standard for E. coli-based Protein Production

Trond Erik Vee Aune, Ph.D.; Jostein Malmo, Ph.D.; Dominik Bahiense de Mello

Vectron Biosolutions

International Markets

In what international markets do you anticipate significant developments in the near future?

Pharma's Almanac

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

Patented Production Strains

Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains

Trond Erik Vee Aune, Ph.D.

Vectron Biosolutions

Biomanufacturing

The Smart Approach to Preclinical Development for Bacterially Expressed Biologics

Trond Erik Vee Aune, Ph.D.

Vectron Biosolutions

Biomanufacturing

Unique Vector Expression Technologies for Boosting Protein Production in E. coli

Trond Erik Vee Aune, Ph.D.

Vectron Biosolutions